FDAnews
www.fdanews.com/articles/152372-zytiga-approved-in-the-eu-for-use-in-the-treatment-of-metastatic-castration-resistant-prostate-cancer-before-chemotherapy

Zytiga Approved in the EU for Use in the Treatment of Metastatic Castration-Resistant Prostate Cancer Before Chemotherapy

January 14, 2013
Janssen announced that the European Commission EC has approved an extension to the license of the oral, once-daily medication Zytiga (abiraterone acetate).
Businesswire